- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03542539
Dermoscopy in Diagnosis of Pigmentary Skin Lesions
The Role of Dermoscopy in Diagnosis of Pigmentary Skin Lesions
Study Overview
Status
Conditions
Detailed Description
Skin color affected by many agents as it is determined by several chromophores such as melanin, hemoglobin and carotenoids. Among these, melanin is the main one responsible for different skin colors.
Melanin is produced by special skin cells called melanocytes and packed in organelles called melanosomes. Sometimes, human skin may present a non-uniform melanin distribution in two different ways, leading to pigmentary disorders.
In the first, melanin concentration increases to levels above normal resulting in hypermelanosis. In the second, the melanin concentration decreases to levels below normal, resulting in hypomelanosis.melanogenesis is acomplex process when disturbed ,it results into various pigmentary disorders either hypo or hyper pigmentation.
These disorders may be congenital or acquired, permenant or temporary, systemic or region restricted).
Pigmentary disorders are include alarge number of heterogenous conditions that are usually characterized by altered melanocyte density, melanin concentration, or both, and result in altered pigmentation of the skin. Some of these disorders are extremely common such as (melisma and vitiligo), whereas others are rare
Differential Diagnosis of Hyper and Hypopigmentation:
Hyperpigmentation Hypopigmentation Postinflammatory hyperpigmentation (acne, psoriasis, atopic and contact dermatitis, lichen planus, trauma, drugs, and fixed-drug eruptions) Melasma Solar lentigines Ephelides (freckles) Café-au-lait macules Nevi Melanoma and precursors Acquired (common) Vitiligo Pityriasis alba Tinea versicolor Postinflammatory hypopigmentation Congenital (uncommon) Albinism Piebaldism Tuberous sclerosis Hypomelanosis of Ito
Several studies have shown that dermoscopy may come in very handy for assisting the noninvasive diagnosis of various general dermatological disorders, including scalp/hair diseases (trichoscopy) , nail/nailfold abnormalities (onychoscopy) , cutaneous infections/infestations (entomodermoscopy) and inflammatory dermatoses (inflammoscopy) .
Dermoscopy is a non-invasive method that allows evaluation of colors and microstructures of the epidermis, the dermoepidermal junction, and the papillary dermis not visible to the naked eye. These structures are specifically correlated to histologic features. The identification of specific diagnostic patterns related to the distribution of colors and dermoscopy structures can better suggest a malignant or benign pigmented skin lesion. The use of this technique provides a valuable aid in diagnosing pigmented skin lesions, This traditionally consists of a magnifier , a non-polarised light source, a transparent plate and a liquid medium between the instrument and the skin .
The increasing use of dermoscopy in general dermatology can be partially explained by commercially available new generations of handheld dermoscopes, which are small enough to be easily placed in every dermatologist's pocket . It is a safe and rapid diagnostic tool that assists in clinical examination and management decision in dermatology
Study Type
Enrollment (Anticipated)
Contacts and Locations
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- all patients attending assuit university hospital clinics complaining of pigmentary skin lesions
Exclusion Criteria:
- no exclusion criteria
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The percentage of patients with pigmentary lesions
Time Frame: 24 hours
|
use of dermoscope for diagnosis
|
24 hours
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- RODIPSL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pigmentary Skin Lesions
-
Mann Eye InstituteSengiRecruitingPigmentary Dispersion Syndrome | Pigmentary Dispersion GlaucomaUnited States
-
University Hospital, MontpellierIntegraGen SARecruiting
-
Sensimed AGPrivate practicioner, Dr Sunaric Mégevand; Orasis, AugenZentrum PajicTerminatedPigmentary Dispersion Syndrome | Pigmentary Glaucoma PatientsSwitzerland
-
Shanghai East HospitalARSMO(Hainan) International Plastic & Aesthetic Hospital Company LimitedNot yet recruitingMesenchymal Stem Cells;Pigmentary Disorders
-
Wright State UniversityCompleted
-
Eurofarma Laboratorios S.A.Not yet recruiting
-
Copenhagen Academy for Medical Education and SimulationTechnical University of DenmarkNot yet recruiting
-
Laboratoires InnotheraTerminated
-
Eurofarma Laboratorios S.A.CompletedSkin Lesion | Skin Care | Skin LesionsBrazil
-
Candela CorporationCompletedPigmented Lesions | Skin TextureUnited States